中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2013年
5期
878-885
,共8页
闫俊灵%狄国虎%丁红%张巍%刘嘉琦%汤苏阳
閆俊靈%狄國虎%丁紅%張巍%劉嘉琦%湯囌暘
염준령%적국호%정홍%장외%류가기%탕소양
器官移植%组织移植%组织细胞移植%脂肪干细胞%间充质干细胞%遗传稳定性%免疫表型%分化潜能%隆胸%自体脂肪颗粒注射%器官移植细胞图片文章
器官移植%組織移植%組織細胞移植%脂肪榦細胞%間充質榦細胞%遺傳穩定性%免疫錶型%分化潛能%隆胸%自體脂肪顆粒註射%器官移植細胞圖片文章
기관이식%조직이식%조직세포이식%지방간세포%간충질간세포%유전은정성%면역표형%분화잠능%륭흉%자체지방과립주사%기관이식세포도편문장
背景:脂肪干细胞具有多向分化潜能,在组织工程和再生医学领域具有广阔的应用前景.目的:随访评估脂肪干细胞在自体脂肪移植隆胸中的技术要点及治疗效果.方法:随访15例自体脂肪颗粒注射隆胸患者3-6个月.脂肪移植隆胸过程分为两期,一期用于脂肪干细胞的分离与扩增,抽出脂肪量为10-20 mL.用胶原酶Ⅰ消化,贴壁培养获得脂肪干细胞,扩增至第2代达到1×108,并进行细胞免疫表型,分化及遗传稳定性鉴定.二期抽取脂肪量300-450 mL,脂肪混合脂肪干细胞用于移植填充.结果与结论:第2代自体脂肪干细胞具有典型的间充质干细胞的特征,移植后3-6个月回访无明显脂肪吸收现象,无感染、疼痛、上肢活动受限等不良反应,隆胸效果良好.作者认为自体脂肪干细胞介导的自体脂肪注射隆胸是一种切实可行有效的方法.
揹景:脂肪榦細胞具有多嚮分化潛能,在組織工程和再生醫學領域具有廣闊的應用前景.目的:隨訪評估脂肪榦細胞在自體脂肪移植隆胸中的技術要點及治療效果.方法:隨訪15例自體脂肪顆粒註射隆胸患者3-6箇月.脂肪移植隆胸過程分為兩期,一期用于脂肪榦細胞的分離與擴增,抽齣脂肪量為10-20 mL.用膠原酶Ⅰ消化,貼壁培養穫得脂肪榦細胞,擴增至第2代達到1×108,併進行細胞免疫錶型,分化及遺傳穩定性鑒定.二期抽取脂肪量300-450 mL,脂肪混閤脂肪榦細胞用于移植填充.結果與結論:第2代自體脂肪榦細胞具有典型的間充質榦細胞的特徵,移植後3-6箇月迴訪無明顯脂肪吸收現象,無感染、疼痛、上肢活動受限等不良反應,隆胸效果良好.作者認為自體脂肪榦細胞介導的自體脂肪註射隆胸是一種切實可行有效的方法.
배경:지방간세포구유다향분화잠능,재조직공정화재생의학영역구유엄활적응용전경.목적:수방평고지방간세포재자체지방이식륭흉중적기술요점급치료효과.방법:수방15례자체지방과립주사륭흉환자3-6개월.지방이식륭흉과정분위량기,일기용우지방간세포적분리여확증,추출지방량위10-20 mL.용효원매Ⅰ소화,첩벽배양획득지방간세포,확증지제2대체도1×108,병진행세포면역표형,분화급유전은정성감정.이기추취지방량300-450 mL,지방혼합지방간세포용우이식전충.결과여결론:제2대자체지방간세포구유전형적간충질간세포적특정,이식후3-6개월회방무명현지방흡수현상,무감염、동통、상지활동수한등불량반응,륭흉효과량호.작자인위자체지방간세포개도적자체지방주사륭흉시일충절실가행유효적방법.
@@@@BACKGROUND: Human adipose stem cells have the capability of multipotential differentiation and have a promising prospect in the field of tissue engineering and regenerative medicine. OBJECTIVE: To evaluate the technology and efficacy of human adipose stem cells in autologous fat grafting breast augmentation. METHODS: Fifteen patients with auto-adipose injection breast augmentation were fol owed-up for 3-6 months. The whole operation was separated into two phases, in the first phase, 15-20 mL adipose tissue was aspirated and digested with col agenase Ⅰ to separate and amplify the human adipose stem cells. When cultured to passage 2, the plastic adherent stem cells were up to 1×108 and verificated by immunophenotype, differentiation and genetic stability assays before transplantation. In the second phase, 300-450 mL adipose tissue was aspirated and transplanted combined with human adipose stem cells. RESULTS AND CONCLUSION: The passage 2 human adipose stem cells exhibited typical mesenchymal stem cells characteristics and maintained genetic stability. The 3-6 months fol ow-up demonstrated that there was no apparent adipose absorption, infection, pain and upper limb activity limitation, and the effect was good. The authors suggested that autologous adipose derived stem cells-mediated auto-adipose injection breast augmentation is a practical and efficacious method.